HighTower Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-29,905
| Closed | -$453K | – | 3560 |
|
|
2023
Q4 | $453K | Hold |
29,905
| – | – | ﹤0.01% | 2384 |
|
|
2023
Q3 | $600K | Hold |
29,905
| – | – | ﹤0.01% | 2099 |
|
|
2023
Q2 | $844K | Hold |
29,905
| – | – | ﹤0.01% | 1856 |
|
|
2023
Q1 | $514K | Sell |
29,905
-269
| -0.9% | -$4.62K | ﹤0.01% | 2077 |
|
|
2022
Q4 | $607K | Buy |
30,174
+247
| +0.8% | +$4.97K | ﹤0.01% | 1975 |
|
|
2022
Q3 | $648K | Sell |
29,927
-291
| -1% | -$6.3K | ﹤0.01% | 1847 |
|
|
2022
Q2 | $848K | Sell |
30,218
-25
| -0.1% | -$702 | ﹤0.01% | 1725 |
|
|
2022
Q1 | $1.4M | Sell |
30,243
-19
| -0.1% | -$877 | ﹤0.01% | 1570 |
|
|
2021
Q4 | $2.54M | Buy |
30,262
+357
| +1% | +$30K | 0.01% | 1223 |
|
|
2021
Q3 | $1.99M | Hold |
29,905
| – | – | 0.01% | 1255 |
|
|
2021
Q2 | $1.59M | Buy |
+29,905
| New | +$1.59M | ﹤0.01% | 1365 |
|